In hepatocellular carcinoma, an PRMT7 enhancer was found to bind to the transcription factor HNF4A to promote the expression of the host gene PRMT7, which ultimately contributes to HCC pathogenesis [53]. This evidence concerns the gene HNF4A and hepatocellular carcinoma.